ArticleScience translational medicine2022

Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia.

Jianzhong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.